StockDriftsStockDriftsCell Biotech (049960) has 8 disclosed insider purchases and 3 disclosed disposals on record, filed by 4 distinct insiders. Together those filings cover ₩869M ($603K) in reported transaction value. The earliest filing StockDrifts holds for Cell Biotech is dated 2024-03-29; the most recent is 2025-12-02. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +10.81%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | BUY | Market Buy | 윤영옥 Youngok Yoon | moving | 16.3K | ₩14,330 | +7.6% | ₩233M ($162K) |
| 2025-11-27 | BUY | Market Buy | 윤영옥 Youngok Yoon | moving | 15.8K | ₩13,100 | +17.7% | ₩207M ($144K) |
| 2025-11-26 | BUY | Market Buy | 윤영옥 Youngok Yoon | moving | 18.2K | ₩13,080 | +17.9% | ₩238M ($165K) |
| 2025-11-25 | BUY | Market Buy | 윤영옥 Youngok Yoon | moving | 4.2K | ₩12,850 | +20.0% | ₩54M ($37K) |
| 2025-11-24 | BUY | Market Buy | 윤영옥 Youngok Yoon | moving | 4.0K | ₩12,790 | +20.6% | ₩51M ($35K) |
| 2025-11-21 | BUY | Market Buy | 윤영옥 Youngok Yoon | moving | 1.6K | ₩12,810 | +20.4% | ₩20M ($14K) |
| 2025-03-30 | BUY | 신규선임 | 정혜지 Hyeji Jeong | implementation | 42.6K | ₩12,590 | +22.5% | ₩536M ($372K) |
| 2025-03-30 | BUY | 신규선임 | 정유숙 Yoosuk Jeong | moving | 42.6K | ₩12,590 | +22.5% | ₩536M ($372K) |
| 2025-03-30 | BUY | 신규선임 | 송수근 Song Soo Geun | Outside Director | 5.9K | ₩12,590 | +22.5% | ₩74M ($51K) |
| 2025-02-10 | BUY | Market Buy | 이상훈 Lee Sang-hoon | moving | 100 | ₩13,910 | +10.9% | ₩1M ($966) |
| 2025-02-03 | SELL | Market Sell | 윤성배 Seongbae Yoon | Managing Director | -2.6K | ₩14,190 | -8.7% | ₩37M ($26K) |
| 2025-01-22 | SELL | Market Sell | 윤성배 Seongbae Yoon | Managing Director | -209 | ₩14,150 | -9.0% | ₩3M ($2K) |
| 2025-01-06 | SELL | Market Sell | 윤성배 Seongbae Yoon | Managing Director | -1.0K | ₩14,380 | -7.2% | ₩14M ($10K) |
| 2024-03-29 | BUY | Market Buy | 은유민 Yumin Lee | moving | 817 | ₩11,970 | +28.8% | ₩10M ($7K) |
Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Cell Biotech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.